Banco Bilbao Vizcaya Argentaria, S.A. Liquidia Corp Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.34 - $8.28 $477,400 - $910,799	-110,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$4.86 - $11.44 $239,112 - $562,848	49,200 Added 80.92%	110,000 $926,000
Q1 2020 May 13, 2020	BUY	$3.31 - $7.15 $201,248 - $434,720	60,800 New	60,800 $286,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.